Contineum Therapeutics, Inc. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Contineum Therapeutics, Inc. (CTNM) is 37.17

According to Contineum Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 37.17. This represents a change of 12.86% compared to the average of 32.93 of the last 4 quarters.

Contineum Therapeutics, Inc. (CTNM) Historical Current Ratio (quarterly & annually)

How has CTNM Current Ratio performed in the past?

The mean historical Current Ratio of Contineum Therapeutics, Inc. over the last ten years is 19.38. The current 37.17 Current Ratio has changed 19.08% with respect to the historical average. Over the past ten years (40 quarters), CTNM's Current Ratio was at its highest in in the June 2024 quarter at 58.92. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Contineum Therapeutics, Inc. (CTNM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Contineum Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Contineum Therapeutics, Inc. (CTNM) Average Current Ratio

How has CTNM Current Ratio performed in the past?

The current Current Ratio of Contineum Therapeutics, Inc. (CTNM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Contineum Therapeutics, Inc. (CTNM) Current Ratio vs. Peers

How is CTNM’s Current Ratio compared to its peers?

Contineum Therapeutics, Inc.’s Current Ratio is greater than Mereo BioPharma Group plc (6.48), greater than Kyverna Therapeutics, Inc. (8.15), greater than Lexeo Therapeutics, Inc. Common Stock (14.16), greater than Silence Therapeutics plc (9.83), greater than AC Immune S.A. (0.87), greater than Alto Neuroscience, Inc. (20.52), greater than Aldeyra The (2.72), greater than Capricor Therapeutics, Inc. (8.42), greater than Candel Therapeutics, Inc. (28.05), greater than Amarin Corporation plc (3.67),

Build a custom stock screener for Contineum Therapeutics, Inc. (CTNM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Contineum Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Contineum Therapeutics, Inc. (CTNM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Contineum Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.